A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus

References

• BakrisGLFonsecaVKatholiRMetabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trialJAMA200429222273615536109
   PubMed Web of Science ®Google Scholar
• BasatOUcakSSeberSAfter myocardial infarction carvedilol improves insulin resistance compared to metoprololClin Res Cardiol2006959910416598518
   PubMedGoogle Scholar
• BellDSLukasMHoldbrookFKThe effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysisCurr Med Res Opin2006222879616466600
   PubMed Web of Science ®Google Scholar
• BhatiaVWildingGEDhindsaGAssociation of poor glycemic control with prolonged hospital stay in patients with diabetes admitted with exacerbation of congestive heart failureEndocr Pract2004104677116033717
   PubMedGoogle Scholar
• DeedwaniaPCGilesTDKlibanerMEfficacy safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HFAm Heart J20051491596715660048
   PubMed Web of Science ®Google Scholar
• DomanskiMKrause-SteinraufHDeedwaniaPThe effect of diabetes on outcomes of patients with advanced heart failure in the BEST trialJ Am Coll Cardiol2003429142212957443
   PubMed Web of Science ®Google Scholar
• DriesDLSweitzerNKDraznerMHPrognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunctionJ Am Coll Cardiol200138421811499733
   PubMed Web of Science ®Google Scholar
• EhmerBvan der DoesRRudorfJInfluence of carvedilol on blood glucose and glycohaemoglobin A1 in non-insulin-dependent diabeticsDrugs198836Suppl 6136402908300
   PubMedGoogle Scholar
• ErdmannELechatPVerkennePResults from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failureEur J Heart Fail200134697911511434
   PubMed Web of Science ®Google Scholar
• FerruaSBobbioMCatalanoEDoes carvedilol impair insulin sensitivity in heart failure patients without diabetesJ Card Fail20051159059416230261
   PubMed Web of Science ®Google Scholar
• FromAMLeibsonCLBursiFDiabetes in heart failure: prevalence and impact on outcome in the populationAm J Med2006119591916828631
   PubMed Web of Science ®Google Scholar
• GersteinHCPogueJMannJFThe relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysisDiabetologia20054817495516059716
   PubMed Web of Science ®Google Scholar
• GiuglianoDAcamporaRMarfellaRMetabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension.A randomized, controlled trialAnn Intern Med199712695599182472
   PubMed Web of Science ®Google Scholar
• HaasSJVosTGilbertREAre beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trialsAm Heart J20031468485314597934
   PubMed Web of Science ®Google Scholar
• HaraYHamadaMShigematsuYEffect of beta-blockers on insulin resistance in patients with dilated cardiomyopathyCirc J200367701412890914
   PubMed Web of Science ®Google Scholar
• IribarrenCKarterAJGoASGlycemic control and heart failure among adult patients with diabetesCirculation200110326687311390335
   PubMed Web of Science ®Google Scholar
• JacobSRettKWicklmayrMDifferential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol studyJ Hypertens199614489948761899
   PubMed Web of Science ®Google Scholar
• KannelWBMcGeeDLDiabetes and cardiovascular disease. The Framingham studyJAMA197924120358430798
   PubMed Web of Science ®Google Scholar
• KatzSDHryniewiczKHriljacIVascular endothelial dysfunction and mortality risk in patients with chronic heart failureCirculation20051113101415655134
   PubMed Web of Science ®Google Scholar
• MohacsiPFowlerMBKrumHShould physicians avoid the use of beta-blockers in patients with heart failure who have diabetes? Results of the COPERNICUS study [Abstract 3551]Circulation2001104II754
   Web of Science ®Google Scholar
• NikolaidisLAPoornimaIParikhPThe effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathyJ Am Coll Cardiol20064718718116682315
   PubMed Web of Science ®Google Scholar
• NikolaidisLASturzuAStolarskiCThe development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathyCardiovasc Res20046129730614736546
   PubMed Web of Science ®Google Scholar
• OpieLHThe metabolic vicious cycle in heart failureLancet20043641733415541431
   PubMed Web of Science ®Google Scholar
• ParsonageWHetmanskiDCowleyADifferentiation of the metabolic and vascular effects of insulin in insulin resistance in patients with chronic heart failureAm J Cardiol20028969670311897212
   PubMed Web of Science ®Google Scholar
• Poole-WilsonPASwedbergKClelandJGComparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trialLancet200336271312853193
   PubMed Web of Science ®Google Scholar
• RefsgaardJThomsenCAndreasenFCarvedilol does not alter the insulin sensitivity in patients with congestive heart failureEur J Heart Fail200244455312167382
   PubMed Web of Science ®Google Scholar
• RemmeWJTorp-PedersenCClelandJGCarvedilol protects better against vascular events than metoprolol in heart failure: results from COMETJ Am Coll Cardiol200769637117336720
   PubMedGoogle Scholar
• ShekellePGRichMWMortonSCEfficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trialsJ Am Coll Cardiol20034115293812742294
   PubMed Web of Science ®Google Scholar
• StrattonIMAdlerAINeilHAAssociation of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ20003214051210938048
   PubMed Web of Science ®Google Scholar
• SuskinNMcKelvieRSBurnsRJGlucose and insulin abnormalities relate to functional capacity in patients with congestive heart failureEur Heart J20002113687510952826
   PubMed Web of Science ®Google Scholar
• SwanJWAnkerSDWaltonCInsulin resistance in chronic heart failure: relation to severity and etiology of heart failureJ Am Coll Cardiol199730527329247528
   PubMed Web of Science ®Google Scholar
• TangWHGlycemic control and treatment patterns in patients with heart failureHeart Fail Monit20065101416547530
   PubMedGoogle Scholar
• TangWHYoungJBCardiomyopathy and heart failure in diabetesEndocrinol Metab Clin North Am20013010314611727399
   PubMed Web of Science ®Google Scholar
• Torp-PedersenCMetraMCharlesworthAEffects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure:data from the Carvedilol Or Metoprolol European Trial (COMET)Heart2007939687317237130
   PubMed Web of Science ®Google Scholar
• TsutamotoTWadaAMatsumotoTRelationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathyJ Am Coll Cardiol20013720869211419892
   PubMed Web of Science ®Google Scholar
• WittelesRMTangWHJamaliAHInsulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic linkJ Am Coll Cardiol200444788115234411
   PubMed Web of Science ®Google Scholar